The time for transparency is now - On Medicine

"But how long can we avoid something that is so obviously contradictory? An entire academic field—an entire sector of the economy—claims to be governed by science, with all the rational obligation that entails; and yet, we see that field, that sector, systematically fail to act scientifically when it comes to data transparency. How many in these communities deprecate the public for unscientific attitudes yet tolerate publication bias and P-hacking and other unscientific practices? These contradictions are becoming more and more difficult to ignore thanks to their own expanding scientific literature. One recent finding comes from the study published in BMC Medicine by Dechartres et al., which found that serious adverse events were underreported or not reported at all when the same trial results were published in an academic journal versus ClinicalTrials.gov."

Read the full article for a discussion on clinical trials, openness, transparency, pharmecueticals, and medicine.